Barclays’s CVRx CVRX Stock Holding History

Barclays’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35,800	Closed	-$1.13M	–	5133
2023 Q4	$1.13M	Buy	+35,800	New	+$672K	﹤0.01%	3350

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barclays's CVRX Position: Q2 2026 in Review

Barclays reduced its CVRx (CVRX) stake by 22% in Q2 2026, selling an estimated $4.23K and leaving 2,348 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4678.

Barclays first reported a position in CVRX in Q1 2022 and has held it in 15 quarters since. The position peaked at $528K in Q1 2023. 88 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

Barclays held 2,348 shares of CVRx worth $12.1K as of Q2 2026.
Barclays sold 655 CVRx shares in Q2 2026, an estimated $4.23K.
CVRx made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4678 holding.
Barclays first reported a position in CVRx in Q1 2022 and has held it in 15 quarters since.
Barclays's CVRx position peaked at $528K in Q1 2023.
88 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.